Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Taiwan
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

ScinoPharm Taiwan Ltd

+ Add to Watchlist

1789:TT

48.20 TWD 0.30 0.62%

As of 01:40:24 ET on 03/05/2015.

Snapshot for ScinoPharm Taiwan Ltd (1789)

Open: 48.90 Day's Range: 48.20 - 48.90 Volume: 681,551
Previous Close: 48.50 52wk Range: 46.70 - 84.23 1-Yr Rtn: -39.17%

Stock Chart for 1789

No chart data available.
  • 1789:TT 48.20
  • 1D
  • 1M
  • 1Y
48.50
Interactive 1789 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 1789

Current P/E Ratio (ttm) 71.2292
Estimated P/E(12/2015) 51.7723
Relative P/E vs. TWSE 4.6098
Earnings Per Share (TWD) (ttm) 0.6767
Est. EPS (TWD) (12/2015) 0.9310
Est. PEG Ratio -
Market Cap (M TWD) 33,882.88
Shares Outstanding (M) 702.96
30 Day Average Volume 1,075,261
Price/Book (mrq) 3.4937
Price/Sale (ttm) 8.2681
Dividend Indicated Gross Yield 2.39%
Cash Dividend (TWD) 1.1538
Dividend Ex-Date 08/07/2014
5 Year Dividend Growth -
Next Earnings Announcement 04/30/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 1789

  • Revenue
  • Net Income (M/TWD)
  • Profit Margin (%)

Company Profile & Key Executives for 1789

ScinoPharm Taiwan Ltd. offers process research and development and the production of active pharmaceutical ingredients. The Company provides services to pharmaceutical industries globally.

Cheng Kao-HuiChairmanChou Patricia PeifenVP:Planning/CFO
Cheng Kuo-HsiVP:Manufacturing CenterLin Ching-WenVP:Sales
More Company Profile & Key Executives for 1789

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil